Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03342664 · ClinicalTrials.gov registry record · NA
MIND: Artemis in the Removal of Intracerebral Hemorrhage
A NA study, sponsored by Penumbra.
- Completed
- Registry status
- NA
- Development phase
- 236
- Enrollment target
NCT03342664 is a NA study that has completed, run by Penumbra. The registered enrollment target is 236 participants.
The verdict
NCT03342664, a NA study, has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- NA
- Development phase
- 236 participants
- Enrollment target
Study Summary
The primary objective of this multicenter randomized controlled study is to compare the safety and efficacy of minimally invasive hematoma evacuation with the Artemis Neuro Evacuation Device to best medical management for the treatment of intracerebral hemorrhage (ICH).
Interventions
- DEVICE Artemis + Medical Management
- OTHER Best Medical Management Alone (MM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2018-02-06 |
| Est. Completion | 2024-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03342664
The ClinicalTrials.gov registry entry for NCT03342664 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 236 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Artemis + Medical Management is the first listed.
NCT03342664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03342664 about?
NCT03342664 is a clinical study titled "MIND: Artemis in the Removal of Intracerebral Hemorrhage". The primary objective of this multicenter randomized controlled study is to compare the safety and efficacy of minimally invasive hematoma evacuation with the Artemis Neuro Evacuation Device to best medical management for the treatment of intracerebral hemorrhage (ICH).
What is the current status of trial NCT03342664?
This trial is currently completed. It is a NA study. The enrollment target is 236 participants. The study started on 2018-02-06. Estimated completion is 2024-09-23.
What interventions are being tested in trial NCT03342664?
The interventions under investigation include: Artemis + Medical Management (DEVICE), Best Medical Management Alone (MM) (OTHER).
Who is sponsoring clinical trial NCT03342664?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.